1
Time to Protection and Adherence Requirements of Raltegravir With or Without Lamivudine in Protection From HIV Infection
Condition(s):HivLast Updated:July 2, 2017Unknown status
Lamivudine: 774 Clinical Trials, Page 1 of 78
Hide Studies Not Open or Pending
2
Bioequivalence Study Between Lamivudine Formulations in the Form of Coated Tablet of 150 mg in Healthy Volunteers
Condition(s):HIV INFECTIONSLast Updated:November 13, 2015Completed
3
Lopinavir/r/ Lamivudine/ Abacavir as an Easy to Use Paediatric Formulation
Condition(s):HIVLast Updated:June 7, 2019Recruiting
4
Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected Adults
Condition(s):HIV InfectionsLast Updated:February 27, 2020Active, not recruiting
5
Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute Exacerbation
Condition(s):Chronic Hepatitis BLast Updated:October 18, 2016Terminated
6
Pharmacokinetics of Lamivudine at Two Different Doses
Condition(s):HIV InfectionsLast Updated:February 11, 2011Completed
7
Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load
Condition(s):Hepatitis B, ChronicLast Updated:December 2, 2015Completed
8
Adefovir and Lamivudine for Entecavir Resistance (ALTER Study)
Condition(s):Chronic Hepatitis BLast Updated:February 17, 2014Completed
9
Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM
Condition(s):HIV Infections; HIV-1-infection; HIV SeropositivityLast Updated:July 31, 2018Recruiting
10
Nevirapine + 3TC Based Maintenance Therapy for HIV Infection
Condition(s):HIV InfectionsLast Updated:July 18, 2018Completed